Coloplast's full year announcement reveals a vast increase in profitability. In
2008/09, the company realised EBIT of DKK 1,395m equal to an EBIT margin of 16%
against 12% last year. In Q4, 2008/09 profit was DKK 406m equal to an EBIT
margin of 18%.
“We have become more efficient and more profitable during the year, so I am
very pleased with the results, especially the Q4 is very strong,” says Lars
Rasmussen, President & CEO.
In line with Coloplast's expectations, the 2008/09 organic revenue growth was
6%, which is also the general market growth. Q4 growth was 7%.
“I'm pleased with the strong increase in profitability, but we still want
higher growth. Now that we have profit under control we have a solid basis for
fulfilling that ambition,” says Lars Rasmussen.
In 2009/10 Coloplast expects an organic revenue growth of 6-7%. Based on
constant exchange rates revenue growth in DKK is expected to be 4-5%. Coloplast
expects an EBIT margin in constant exchange rates of 17-18% and in DKK of
16-17%.
PRESS CONTACT
Morten Sørensen
Media Relations Manager, Corporate Communications
+45 4911 2632
dkmoso@coloplast.com
INVESTOR RELATIONS
Ian S. E. Christensen
Head of Investor Relations
+45 4911 1301
dkisec@coloplast.com
